AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹4,496 Cr | ₹2,938 Cr | ₹2,429 Cr | ₹1,622 Cr | ₹1,342 Cr |
What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2023 | ₹4,496 Cr |
Mar2022 | ₹2,938 Cr |
Mar2021 | ₹2,429 Cr |
Mar2020 | ₹1,622 Cr |
Mar2019 | ₹1,342 Cr |
How is Capital Work in Progress of AUROBINDO PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2023 | ₹4,496 Cr | 53.07 | |
Mar2022 | ₹2,938 Cr | 20.94 | |
Mar2021 | ₹2,429 Cr | 49.77 | |
Mar2020 | ₹1,622 Cr | 20.85 | |
Mar2019 | ₹1,342 Cr | - |
Compare Capital Work in Progress of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹67,536.7 Cr | 1.9% | 3.6% | 87.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.9% |
3.6% |
87.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses